Chiara La Morgia Selected Research

idebenone

1/2021	Therapeutic Options in Hereditary Optic Neuropathies.
1/2020	Idebenone increases chance of stabilization/recovery of visual acuity in OPA1-dominant optic atrophy.
12/2017	International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy.
2/2013	Idebenone treatment in patients with OPA1-mutant dominant optic atrophy.
9/2011	Idebenone treatment in Leber's hereditary optic neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara La Morgia Research Topics

Disease

22	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2022 - 12/2006
14	Optic Nerve Diseases (Optic Neuropathy) 01/2021 - 01/2007
11	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 08/2010
10	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2021 - 05/2009
9	Optic Atrophy 01/2022 - 02/2008
5	Ganglion Cysts (Ganglion) 01/2022 - 09/2014
5	MELAS Syndrome (Syndrome, MELAS) 01/2021 - 05/2009
4	Stroke (Strokes) 01/2022 - 05/2009
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2017
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2016
4	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2018 - 02/2008
4	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2018 - 02/2008
4	Deafness (Deaf Mutism) 07/2015 - 02/2008
3	Lactic Acidosis 01/2022 - 05/2009
3	Wolfram Syndrome (Syndrome, Wolfram) 01/2022 - 01/2020
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
3	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 01/2022 - 05/2014
3	Parkinsonian Disorders (Parkinsonism) 01/2018 - 07/2015
2	Narcolepsy 01/2022 - 06/2014
2	Leigh Disease (Leigh's Disease) 01/2022 - 05/2014
2	Atrophy 01/2021 - 01/2012
2	Brain Diseases (Brain Disorder) 01/2021 - 01/2021
2	Dementia (Dementias) 01/2021 - 07/2015
2	Hereditary Spastic Paraplegia 06/2020 - 05/2009
2	Cataplexy 01/2020 - 06/2014
2	Ataxia (Dyssynergia) 01/2020 - 02/2008
2	Cataract (Cataracts) 08/2014 - 05/2009
1	Overweight 01/2022
1	Hypertriglyceridemia 01/2022
1	COVID-19 01/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 10/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2020
1	Spinocerebellar ataxia 28 06/2020
1	Hereditary Sensory and Autonomic Neuropathy Type Ie 01/2020
1	Epilepsy (Aura) 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Sleepiness 01/2018
1	Hearing Loss (Hearing Impairment) 01/2016
1	Cognitive Dysfunction 07/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2015
1	Auditory neuropathy 03/2015
1	Deglutition Disorders (Dysphagia) 08/2014
1	Muscular Diseases (Myopathy) 08/2014
1	Persistent Vegetative State (Vegetative State) 06/2014
1	Cerebellar Ataxia, Deafness, and Narcolepsy 05/2014
1	Calcinosis 08/2011
1	Blindness (Hysterical Blindness) 02/2011
1	Glaucoma 01/2011
1	Seasonal Affective Disorder 01/2011
1	Photophobia (Light Sensitivity) 01/2011

Drug/Important Bio-Agent (IBA)

26	Mitochondrial DNA (mtDNA)IBA 01/2022 - 12/2006
18	Retinaldehyde (Retinal)IBA 01/2022 - 10/2011
8	melanopsinIBA 01/2022 - 08/2010
5	idebenoneIBA 01/2021 - 09/2011
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2018
3	Pharmaceutical PreparationsIBA 01/2021 - 12/2016
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 08/2010
3	CalciumIBA 06/2020 - 08/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2017
2	OrexinsIBA 01/2022 - 06/2014
2	MethyltransferasesIBA 01/2020 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 01/2020 - 05/2009
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2017 - 02/2011
2	MelatoninIBA 06/2014 - 08/2010
1	HDL CholesterolIBA 01/2022
1	NADH DehydrogenaseIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Biological ProductsIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 12/2020
1	fibroblast growth factor 21IBA 10/2020
1	Growth Differentiation Factor 15IBA 10/2020
1	Transfer RNA (tRNA)IBA 10/2020
1	m-AAA proteasesIBA 06/2020
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2020
1	purineIBA 01/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 11/2018
1	SuspensionsIBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2016
1	Proteins (Proteins, Gene)FDA Link 08/2015
1	Cytochromes b (Cytochrome b)IBA 08/2014
1	DNA (Cytosine-5-)-Methyltransferases (DNA (Cytosine 5) Methyltransferase)IBA 05/2014
1	Carisoprodol (Soma)FDA LinkGeneric 01/2012
1	Phosphorus (Red Phosphorus)IBA 01/2011

Therapy/Procedure

5	Therapeutics 01/2021 - 02/2011
1	Lasers (Laser) 01/2022
1	Intravitreal Injections 12/2020
1	Transplantation 01/2020
1	Phototherapy (Light Therapy) 01/2017
1	Cochlear Implantation 03/2015